To determine the gene expression of IFNAR1, IFNAR2 and MxA protein and the association with IFNbeta treatment response in MS patients. MS patients treated with IFNbeta had a significant decrease in IFNAR1 and IFNAR2 expression, and a significant increase in MxA compared to non-treated patients and healthy controls. Also, those patients who had a good response to treatment had a significant decrease in IFNAR1 and IFNAR2 expression compared to non-responders, non-treated patients and healthy controls. IFNbeta influences the expression of its receptors, and is greater in patients who respond to IFNbeta treatment. This down-regulation could be indicative of the response to IFNbeta.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2006.11.010DOI Listing

Publication Analysis

Top Keywords

ifnar1 ifnar2
12
ifnbeta treatment
8
decrease ifnar1
8
ifnar2 expression
8
non-treated patients
8
patients healthy
8
healthy controls
8
patients
7
expression
5
ifnbeta
5

Similar Publications

Autosomal recessive deficiency of the IFNAR1 or IFNAR2 chain of the human type I IFN receptor abolishes cellular responses to IFN-α, -β, and -ω, underlies severe viral diseases, and is globally very rare, except for IFNAR1 and IFNAR2 deficiency in Western Polynesia and the Arctic, respectively. We report 11 human IFNAR1 alleles, the products of which impair but do not abolish responses to IFN-α and -ω without affecting responses to IFN-β. Ten of these alleles are rare in all populations studied, but the remaining allele (P335del) is common in Southern China (minor allele frequency ≈2%).

View Article and Find Full Text PDF

The goal of our study was to explore the association of the polymorphisms in the JAK/STAT pathway among Moroccan COVID-19 patients, using a case-control approach. Next-generation sequencing was employed to investigate the IFNAR1, IFNAR2, JAK1, TYK2, STAT2, and IRF9 genes within the JAK/STAT pathway. We also performed an in silico study to examine the rare variants in this pathway.

View Article and Find Full Text PDF
Article Synopsis
  • Ongoing outbreaks of various viral infections highlight the urgent need for new antiviral compounds, with a focus on immunomodulatory drugs due to the immunotoxic properties of many viruses.
  • A synthetic compound related to indole-3-carboxylic acid derivatives (referred to as XXV) has been developed, demonstrating antiviral and interferon-inducing activities in a macrophage-like cell model.
  • The study utilized real-time PCR to show that XXV significantly stimulates the expression of toll-like receptors, interferons, and cytokines, indicating its role as an activator of innate immunity and its potential in fighting viral pathogens.
View Article and Find Full Text PDF
Article Synopsis
  • Janus kinases (JAKs) play a crucial role in regulating signaling and gene transcription by binding to class I and II cytokine receptors, particularly in the context of type I interferons (IFNs).
  • Research showed that modified IFNARs maintain similar IFN signaling levels, while specific versions of IFNAR2 perform poorly despite having necessary docking sites for JAKs and STATs.
  • JAKs exhibit promiscuous binding to various cytokine receptors, influencing cross-phosphorylation and signaling efficiency, which contributes to the different signaling outcomes observed in different cell types.
View Article and Find Full Text PDF

African swine fever virus (ASFV) is a nuclear cytoplasmic large DNA virus (NCLDV) that causes devastating hemorrhagic diseases in domestic pigs and wild boars, seriously threatening the development of the global pig industry. IFN-I plays an important role in the body's antiviral response. Similar to other DNA viruses, ASFV has evolved a variety of immune escape strategies to antagonize IFN-I signaling and maintain its proliferation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!